MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

About this update from Mangoceuticals, Inc.

[{"type":"text","content":"Dallas, TX Based Men's Health Telemedicine Company Announces Successful Participation in Beijing ExhibitDALLAS, TX / ACCESSWIRE / August 8, 2024 / Mangoceuticals, Inc. (NASDAQ:MGRX) (\"MangoRx\" or the \"Company\"), a leader in developing, marketing, and selling a variety of men's health and wellness products, is pleased to announce the receipt of its first Request for Proposal (RFP) from its distributor, the International Society of Frontier Life Sciences and Technology (ISFLST). This RFP focuses on the formulation, production, and packaging of a new male enhancement non-prescription product, intended to be introduced and sold in the Chinese market as a natural solution for men's health.This collaboration aligns MangoRx's advanced formulation, manufacturing, branding capabilities and commitment to quality with ISFLST's vision for a superior men's health and enhancement product. The proposed product will be manufactured in the USA, utilizing GMP-compliant facilities. The anticipated pilot program will explore initial distribution across 50 retail locations throughout China, with the potential to scale to up to 5,000 locations based on market demand analysis.Jacob Cohen, CEO and Co-Founder of MangoRx commented, \"this RFP represents a significant milestone in the Company's efforts to expand its current product offerings and to reach new international markets. We are very pleased with the amount of traction and success that our partners at ISFLST have achieved in such a little amount of time while representing MangoRx and our products throughout Asia. This is a true testament to MangoRx's branding efforts and dedication to quality in our products, compounding and innovative formulation capabilities.\"Dr. Douglas Christianson, the Company's Director of Medical Research and Product Innovation will be spearheading the RFP process and will be working closely with our partners at the ISFLST to develop and finalize the male enhancement product's formulation.The initiative to address the need for innovative men's health products has been well received by the region, with several associations preparing for their market launch. As the men's health platform gains traction, the ISFLST has also expressed interest in developing similar solutions for women's health.Furthermore, MangoRx's current male performance and hair growth products, Mango ...

More updates from Mangoceuticals, Inc.